US Patent 11787796 Plasma Kallikrein inhibitors and uses thereof
Patent 11787796 was granted and assigned to Takeda Pharmaceutical Company on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Oct, 2023
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+190 characters)
US Patent 11787796 Plasma Kallikrein inhibitors and uses thereof
Article
Patent abstract
The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alastair Rae
Jeremy Mark Travins
John Mark Ellard
Nikolaos Papaioannou
Sarah Jocelyn Fink
Date of Patent
October 17, 2023
Patent Application Number
17024437
Date Filed
September 17, 2020
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11787796 Plasma Kallikrein inhibitors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
